Status:
COMPLETED
Mailed FIT Outreach 2022
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Conditions:
Colorectal Cancer
Colon Cancer
Eligibility:
All Genders
50-74 years
Phase:
NA
Brief Summary
This project aims to evaluate different approaches to increase colorectal cancer screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic...
Detailed Description
While colonoscopy procedures are recommended by guidelines for early detection of colorectal cancer, colonoscopy access remains limited due to delays in screening due to the pandemic and capacity issu...
Eligibility Criteria
Inclusion
- Patients ages 50-74 with Penn as preferred lab
- Followed by Primary Care with a participating Penn Medicine PCP listed and at least one visit in the last 2 years
- Not up to date on colorectal cancer screening per Health Maintenance (no colonoscopy in the last 10 years, stool testing in the last year, flexible sigmoidoscopy in the last 5 years, FIT-DNA in the last 3 years).
Exclusion
- Personal or significant family history of CRC, colonic polyps, hereditary nonpolyposis colorectal cancer syndrome, familial adenomatous polyposis syndrome, other gastrointestinal cancer, gastrointestinal bleeding, iron-deficiency anemia, or inflammatory bowel disease
- History of total colectomy, dementia or metastatic cancer
- Currently on hospice or receiving palliative care
- Uninsured or self-pay patients
- Currently scheduled for a colonoscopy or sigmoidoscopy
Key Trial Info
Start Date :
May 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 13 2022
Estimated Enrollment :
5460 Patients enrolled
Trial Details
Trial ID
NCT05341622
Start Date
May 27 2022
End Date
December 13 2022
Last Update
July 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn Medicine
Philadelphia, Pennsylvania, United States, 19104